Item 4 — Purpose of Transaction
Effective January 2, 2026, the Reporting Persons sold approximately 2.8% of the Issuer's outstanding Common Stock through open market transactions, since their filing of Amendment No. 8 to this Schedule 13D filed on December 29, 2025. The Reporting Persons no longer believe that the Issuer represents an attractive investment based on the Issuer's business prospects and strategy, and intend to divest of their remaining shares of Common Stock in open market transactions over the next six (6) months. The Reporting Persons do not expect to have further communications with the board of directors of the Issuer, members of management and/or other shareholders with respect to operational, strategic, financial or governance matters. This represents a change in purpose from the initial investment. Notwithstanding the foregoing, the Reporting Persons reserve the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed of, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Persons, market conditions or other factors. Other than as set forth above, the Reporting Persons do not have any plans or proposals as of the date of this filing which relate to or would result in any of the actions enumerated in Item 4 of the instructions to Schedule 13D.